This is road map in Canada:
Key Milestones
Milestones title Date
Call for patient/clinician input open 16-Aug-24
Call for patient/clinician input closed 15-Oct-24
Submission received 29-Oct-24
Submission accepted 13-Nov-24
Review initiated 14-Nov-24
Draft Canada's Drug Agency review report(s) provided to sponsor for comment 05-Feb-25
Deadline for sponsors comments 14-Feb-25
Canada's Drug Agency review report(s) and responses to comments provided to sponsor 13-Mar-25
Expert committee meeting (initial) 26-Mar-25
Draft recommendation issued to sponsor April 07, 2025
To
April 09, 2025
Draft recommendation posted for stakeholder feedback 17-Apr-25
End of feedback period 05-May-25
https://www.cda-amc.ca/trofinetide
- Forums
- ASX - By Stock
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.30%
!
$13.27

This is road map in Canada: Key Milestones Milestones title Date...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.27 |
Change
-0.040(0.30%) |
Mkt cap ! $1.650B |
Open | High | Low | Value | Volume |
$13.50 | $13.58 | $12.96 | $1.097M | 82.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 384 | $13.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.29 | 75 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 375 | 13.170 |
3 | 459 | 13.160 |
2 | 300 | 13.150 |
4 | 1184 | 13.140 |
4 | 701 | 13.130 |
Price($) | Vol. | No. |
---|---|---|
13.220 | 197 | 3 |
13.230 | 527 | 5 |
13.240 | 438 | 4 |
13.250 | 1300 | 7 |
13.260 | 389 | 3 |
Last trade - 10.23am 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online